$23.47
+0.0200 (+0.0853%)
At Close: Jun 03, 2026
Assertio (ASRT) Reports Q2 Loss, Beats Revenue Estimates
07:56pm, Monday, 11'th Aug 2025
Assertio (ASRT) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.1. This compares to a loss of $0.04 per share a year ago.
Assertio Holdings, Inc. (ASRT) Q2 2025 Earnings Call Transcript
07:41pm, Monday, 11'th Aug 2025
Assertio Holdings, Inc. (NASDAQ:ASRT ) Q2 2025 Earnings Conference Call August 11, 2025 4:30 PM ET Company Participants Ajay Patel - Executive VP & CFO Brendan P. O'Grady - CEO & Director Conference C
Assertio Reports Second Quarter 2025 Financial Results
04:05pm, Monday, 11'th Aug 2025
Second Quarter Total Net Product Sales of $28.8 Million, Cash and Investments Increase to $98.2 Million Narrows Guidance on Continued Progress Implementing Long-Term Business Strategy LAKE FOREST, Ill
ATTENTION NASDAQ: SPPI INVESTORS: Contact Berger Montague About a Spectrum Pharmaceuticals Class Action Lawsuit
11:46am, Thursday, 07'th Aug 2025
PHILADELPHIA, Aug. 07, 2025 (GLOBE NEWSWIRE) -- National plaintiffs' law firm Berger Montague PC is investigating securities fraud claims against Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) (“Spe
Berger Montague PC Investigating Claims on Behalf of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) Investors
03:41pm, Wednesday, 06'th Aug 2025
PHILADELPHIA , Aug. 6, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC is investigating securities fraud claims against Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) ("Spectr
Assertio Holdings, Inc. to Report Second Quarter 2025 Financial Results on August 11, 2025
08:30am, Tuesday, 05'th Aug 2025
LAKE FOREST, Ill., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT) today announced that it will release second quarter 2025 financial res
New Strong Sell Stocks for July 8th
07:31am, Tuesday, 08'th Jul 2025
ASRT, BLIN and BAH have been added to the Zacks Rank #5 (Strong Sell) List on July 8, 2025.
New Strong Sell Stocks for June 30th
07:05am, Monday, 30'th Jun 2025
AEG, APOG and ASRT have been added to the Zacks Rank #5 (Strong Sell) List on June 30, 2025.
New Strong Sell Stocks for June 25th
07:31am, Wednesday, 25'th Jun 2025
ASRT, BLIN and AMKR have been added to the Zacks Rank #5 (Strong Sell) List on June 25 2025.
New Strong Sell Stocks for June 18th
06:11am, Wednesday, 18'th Jun 2025
APLE, ASRT and BOOT have been added to the Zacks Rank #5 (Strong Sell) List on June 18, 2025.
Assertio to Participate in the Alliance Global Partners Healthcare Company Showcase on May 21, 2025
04:10pm, Monday, 19'th May 2025
LAKE FOREST, Ill., May 19, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT) today announced that Brendan O'Grady, Chief Executive Officer, will pre
Assertio Holdings, Inc. (ASRT) Q1 2025 Earnings Call Transcript
08:17pm, Monday, 12'th May 2025
Assertio Holdings, Inc. (NASDAQ:ASRT ) Q1 2025 Earnings Conference Call May 12, 2025 4:30 PM ET Company Participants Matt Kreps - Investor Relations Brendan O'Grady - Chief Executive Officer Ajay Pate
Assertio (ASRT) Reports Q1 Loss, Misses Revenue Estimates
06:20pm, Monday, 12'th May 2025
Assertio (ASRT) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to earnings of $0.04 per share a year ago.
Assertio Reports First Quarter 2025 Financial Results
04:01pm, Monday, 12'th May 2025
First Quarter Total Net Product Sales of $26.0 Million, In Line with 2025 Outlook
Assertio Holdings, Inc. to Report First Quarter 2025 Financial Results on May 12, 2025
08:15am, Monday, 05'th May 2025
LAKE FOREST, Ill., May 05, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT) today announced that it will release first quarter 2025 financial resul
Sign In
Buy ASRT